W&F Issue 9 2018

www.wealthandfinance-news.com 18 Wealth & Finance International - Issue 9 - 2018 As pioneers in the healthcare and pharmaceutical industries, Micro Labs aims to change the status quo. As pace-setters in the market, they hope to become the leading example for others, especially in regard to sustainable business practices. This goes hand in hand with their aim to be a $1 billion company in just two years’ time. This is very much par for the course for a company that has always dreamed big, and has, so far at least, achieved those goals and more. Working out of the bustling city of Bangalore, Micro Labs has state-of-the-art facilities, and world-class R&D centres that have been the prominent drivers in their efforts to become one of the market leaders in a notoriously competitive sector. This forms an integral part of the firm’s vision – to become the undisputed leader in the development, manufacture, and sales of premium pharmaceutical products. From the outset, Micro Labs have held themselves to the highest standards of the industry, realising that enduring success comes to those that align their practices alongside those of global institutions. In this, they have set aside a series of fundamental business beliefs namely; a dedication to quality, ethics, client-centricity, and respect. For the last ten years, these elements have served as the recipe for Micro Labs’ success. Their commitment to quality has yielded top of the line pharmaceutical products that have stood shoulder to shoulder with those of any global business. On the back of this, they have grown organically year on year, celebrating unprecedented growth in the Indian market. As such, many of their facilities have been approved by the Food and Drugs Administration (FDA), Medicine and Healthcare Regulatory Agency (MHRA) and the World Health Organisation, to name but a few. In their constant pursuit of perfection, Micro Labs have left a truly global footprint in the market, becoming a recognised expert in their field. For all of these reasons and many more besides, Micro Labs Ltd are deserving winners of the title of ‘Most Outstanding Pharmaceutical R&D Firm’ in India. They have forged a global reputation in a challenging arena through a dedication to quality, and a remarkable work ethos that puts the client at the centre of the process. They remain a company to watch in the years to come, as they look to achieve that $1 billion valuation. Micro Labs Ltd is a multi-faceted healthcare organisation operating out of Bangalore, India. In June, Micro Labs was awarded the title of Most Outstanding Pharmaceutical R&D Firm in India, as part of Wealth & Finance International’s Finest in Finance Awards programme. Following this success, we looked to profile this extraordinary firm to find out how they hope to reinvigorate their industry. Becoming the Cornerstone of Pharmaceutical R&D 1807WF08 Company: Micro Labs Ltd Address: 27, Race Course Road, Bangalore, 560 001, India Telephone: +91 80 2237 0451-54 Website: www.microlabsltd.com